{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:56:43Z","timestamp":1792796203909,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.radonc.2022.06.022","type":"journal-article","created":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T19:47:49Z","timestamp":1656877669000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Efficacy and safety of recombinant human endostatin combined with whole-brain radiation therapy in patients with brain metastases from non-small cell lung cancer"],"prefix":"10.1016","volume":"174","author":[{"given":"Lingjuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.06.022_b0005","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.20.01255","article-title":"Survival in patients with brain metastases: Summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient","volume":"38","author":"Sperduto","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0010","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","article-title":"Estimating survival in patients with lung cancer and brain metastases: An update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA)","volume":"3","author":"Sperduto","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/neuros\/nyx522","article-title":"Stereotactic radiosurgery in the management of limited (1\u20134) brain metasteses: Systematic review and international stereotactic radiosurgery society practice guideline","volume":"83","author":"Chao","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.radonc.2022.06.022_b0020","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.prro.2011.12.004","article-title":"Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline","volume":"2","author":"Tsao","year":"2012","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0025","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","article-title":"Current approaches to the management of brain metastases","volume":"17","author":"Suh","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1470-2045(09)70389-4","article-title":"Whole-brain irradiation for patients with brain metastases: still the standard of care","volume":"11","author":"Mahmood","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0045","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0140-6736(16)30825-X","volume":"388","author":"Mulvenna","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2022.06.022_b0050","first-page":"CD003869","article-title":"Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases","volume":"1","author":"Tsao","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.radonc.2022.06.022_b0055","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1088\/0031-9155\/49\/19\/002","article-title":"The relationship between temporal variation of hypoxia, polarographic measurements and predictions of tumour response to radiation","volume":"49","author":"Toma-Da u","year":"2004","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2022.06.022_b0060","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/j.prro.2021.01.011","article-title":"Timing of adjuvant fractionated stereotactic radiosurgery affects local control of resected brain metastases","volume":"11","author":"Roth O\u2019Brien","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0065","first-page":"777","article-title":"Antineoplastic therapy combined with whole brain radiation compared with whole brain radiation alone for brain metastases: a systematic review and meta-analysis","volume":"17","author":"Meng","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.radonc.2022.06.022_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-28-1","article-title":"Whole brain radiotherapy with radiosensitizer for brain metastases","volume":"28","author":"Viani","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.radonc.2022.06.022_b0075","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.ijrobp.2011.09.050","article-title":"Effect of recombinant human endostatin on radiosensitivity in patients with non-small-cell lung cancer","volume":"83","author":"Jiang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.06.022_b0080","doi-asserted-by":"crossref","first-page":"111607","DOI":"10.1016\/j.biopha.2021.111607","article-title":"Vascular normalization in immunotherapy: A promising mechanisms combined with radiotherapy","volume":"139","author":"Liu","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.radonc.2022.06.022_b0085","article-title":"Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia","volume":"5","author":"Zhu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2022.06.022_b0090","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-physiol-020518-114700","article-title":"Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges","volume":"81","author":"Martin","year":"2019","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.radonc.2022.06.022_b0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13014-020-01646-9","article-title":"Efficacy and safety of recombinant human endostatin combined with radiotherapy or chemoradiotherapy in patients with locally advanced non-small cell lung cancer: a pooled analysis","volume":"15","author":"Zhang","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10456-017-9552-y","article-title":"Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?","volume":"20","author":"Ramjiawan","year":"2017","journal-title":"Angiogenesis"},{"key":"10.1016\/j.radonc.2022.06.022_b0110","doi-asserted-by":"crossref","first-page":"689132","DOI":"10.3389\/fimmu.2021.689132","article-title":"The combination of immune checkpoint blockade and angiogenesis inhibitors in the treatment of advanced non-small cell lung cancer","volume":"12","author":"Ren","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2022.06.022_b0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11684-012-0176-8","article-title":"Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives","volume":"6","author":"Shang","year":"2012","journal-title":"Front Med"},{"key":"10.1016\/j.radonc.2022.06.022_b0120","doi-asserted-by":"crossref","first-page":"17561","DOI":"10.1073\/pnas.1215397109","article-title":"Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy","volume":"109","author":"Huang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.radonc.2022.06.022_b0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.radonc.2022.06.022_b0130","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.bbagen.2015.09.007","article-title":"Endostatin\u2019s emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications","volume":"1850","author":"Walia","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.radonc.2022.06.022_b0135","first-page":"283","article-title":"Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients","volume":"8","author":"Wang","year":"2005","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"10.1016\/j.radonc.2022.06.022_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00524","article-title":"Monitoring the process of endostar-induced tumor vascular normalization by non-contrast intravoxel incoherent motion diffusion-weighted MRI","volume":"8","author":"Pan","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.radonc.2022.06.022_b0150","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrn2175","article-title":"Angiogenesis in brain tumours","volume":"8","author":"Jain","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.radonc.2022.06.022_b0155","doi-asserted-by":"crossref","first-page":"745","DOI":"10.21037\/tlcr-20-500","article-title":"The effect of combining Endostar with radiotherapy on blood vessels, tumor-associated macrophages, and T cells in brain metastases of Lewis lung cancer","volume":"9","author":"Peng","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.radonc.2022.06.022_b0160","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s12094-013-1129-7","article-title":"Recombinant human endostatin combined with radiotherapy in the treatment of brain metastases of non-small cell lung cancer","volume":"16","author":"Jiang","year":"2014","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0165","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/cns.12.29","article-title":"Imaging biomarkers for antiangiogenic therapy in malignant gliomas","volume":"2","author":"Leu","year":"2013","journal-title":"CNS Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0175","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1212\/WNL.0000000000000402","article-title":"Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma","volume":"82","author":"Nowosielski","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.radonc.2022.06.022_b0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nicl.2018.07.001","article-title":"Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas","volume":"20","author":"Kong","year":"2018","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.radonc.2022.06.022_b0185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11060-016-2102-4","article-title":"Perfusion MRI as the predictive\/prognostic and pharmacodynamic biomarkers in recurrent malignant glioma treated with bevacizumab: a systematic review and a time-to-event meta-analysis","volume":"128","author":"Choi","year":"2016","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0190","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.clon.2014.06.010","article-title":"Magnetic resonance imaging-based tumour perfusion parameters are biomarkers predicting response after radiation to brain metastases","volume":"26","author":"Jakubovic","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2022.06.022_b0195","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2478\/raon-2018-0022","article-title":"Perfusion magnetic resonance imaging changes in normal appearing brain tissue after radiotherapy in glioblastoma patients may confound longitudinal evaluation of treatment response","volume":"52","author":"Fahlstrom","year":"2018","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0200","doi-asserted-by":"crossref","first-page":"563932","DOI":"10.3389\/fonc.2020.563932","article-title":"Evaluating the treatment efficacy of nano-drug in a lung cancer model using advanced functional magnetic resonance imaging","volume":"10","author":"Huang","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0205","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3389\/fonc.2020.01376","article-title":"Application of IVIM-DWI in detecting the tumor vasculogenic mimicry under antiangiogenesis combined with oxaliplatin treatment","volume":"10","author":"Liang","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0210","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.3390\/curroncol28050339","article-title":"Cognitive assessment tools recommended in geriatric oncology guidelines: A rapid review","volume":"28","author":"Tuch","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0215","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00415-019-09506-7","article-title":"Cognitive assessment tools for mild cognitive impairment screening","volume":"268","author":"Zhuang","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.radonc.2022.06.022_b0220","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/cam4.1046","article-title":"Dynamic contrast-enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases","volume":"6","author":"Hatzoglou","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2022.06.022_b0225","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2217\/fon-2021-1239","article-title":"Efficacy and safety of recombinant human endostatin during peri-radiotherapy period in advanced non-small-cell lung cancer","volume":"18","author":"Zhu","year":"2022","journal-title":"Future Oncol"},{"key":"10.1016\/j.radonc.2022.06.022_b0230","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2007.06.155","article-title":"Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR\/Flk-1 of endothelial cells","volume":"361","author":"Ling","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.radonc.2022.06.022_b0235","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5045\/br.2013.48.4.242","article-title":"Next generation sequencing: new tools in immunology and hematology","volume":"48","author":"Mori","year":"2013","journal-title":"Blood Res"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022041834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022041834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:21:59Z","timestamp":1759123319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022041834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":47,"alternative-id":["S0167814022041834"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.06.022","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of recombinant human endostatin combined with whole-brain radiation therapy in patients with brain metastases from non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}